New drug combo shows promise for Hard-to-Treat cancers

NCT ID NCT05101070

Recruiting now Disease control Sponsor: Shionogi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called S-531011, alone or with other cancer treatments, in people with advanced solid tumors that have not responded to standard therapies. The goal is to find safe doses and see if the drug can shrink tumors or slow their growth. About 282 adults with various solid tumors will participate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMORS

Contacts and locations

Locations

Angeles Clinic and Research Center
ACTIVE_NOT_RECRUITING

Los Angeles, California, 90025, United States
Fox Chase Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19111, United States
Henry Ford Health Center
ACTIVE_NOT_RECRUITING

Detroit, Michigan, 48202, United States
MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
National Cancer Center Hospital
RECRUITING

Chuo Ku, Tokyo, Japan
National Cancer Center Hospital East
RECRUITING

Kashiwa, Chiba, Japan
The University of Osaka Hospital
RECRUITING

Suita, Osaka, Japan
University of Florida Health
RECRUITING

Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.